Moreover, we lack experimental validation in clinical COPD patients sample, and the relationship between FOXO1 and DDX17 and symptomseverity, quality of life, and frequencyof acute exacerbations in COPD remains to be confirmed. This evidence concerns the gene FOXO1 and chronic obstructive pulmonary disease.